Healthcare -
Biotechnology - NASDAQ - US
$ 2.15
-9.66 %
$ 18.5 M
Market Cap
-0.84
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
27.76%
Net Income
Estimate
21.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Lisata Therapeutics, Inc.
LSTA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart LSTA
EBIT FORECAST
EBIT Forecast Chart LSTA
NET INCOME FORECAST
Net Income Chart LSTA